Can high-dose interleukin-2 be replaced with lower-dose, outpatient regimens for metastatic renal cell carcinoma?

Christopher G. Wood

doi:10.1038/ncpuro0183

Can high-dose interleukin-2 be replaced with lower-dose, outpatient regimens for metastatic renal cell carcinoma?

Christopher G. Wood

Urology

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	218-219
Number of pages	2
Journal	Nature Clinical Practice Urology
Volume	2
Issue number	5
DOIs	https://doi.org/10.1038/ncpuro0183
State	Published - May 2005

Keywords

Interferon
Interleukin-2
Metastasis
Renal cell carcinoma

ASJC Scopus subject areas

Urology

Access to Document

10.1038/ncpuro0183

Cite this

@article{b15543f7811a49f6b3911c15511a008e,

title = "Can high-dose interleukin-2 be replaced with lower-dose, outpatient regimens for metastatic renal cell carcinoma?",

keywords = "Interferon, Interleukin-2, Metastasis, Renal cell carcinoma",

author = "Wood, {Christopher G.}",

year = "2005",

month = may,

doi = "10.1038/ncpuro0183",

language = "English (US)",

volume = "2",

pages = "218--219",

journal = "Nature Clinical Practice Urology",

issn = "1743-4270",